多发性骨髓瘤 CAR-NK 细胞治疗的最新进展:细胞来源与靶抗原的综合综述 State of the Art of CAR-NK Cell Therapy in Multiple Myeloma: A Comprehensive Review of Cell Sources and Target Antigens. PubMed 2025/11/20 发表Int J Mol SciQ1 · IF 5.6(JCR 2025) 靶点:CD38靶点:CD70靶点:BCMA技术:CAR-T技术:CAR-NK技术:NK 细胞
靶向 CD70 的 iPSC 衍生 CAR-NK 细胞对肿瘤和同种异体反应性 T 细胞表现出强效功能 CD70-targeted iPSC-derived CAR-NK cells display potent function against tumors and alloreactive T cells. PubMed 2025/01/09 发表Cell Rep MedQ1 · IF 14(JCR 2025) 靶点:CD70技术:CAR-NK技术:NK 细胞技术:诱导多能干细胞肾癌淋巴瘤